表紙画像

Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression

Liver cancer represents a substantial global health challenge, contributing significantly to worldwide morbidity and mortality. It has long been understood that tumors are not composed solely of cancerous cells, but also include a variety of normal cells within their structure. These tumor-associate...

詳細記述

保存先:
主要な著者: Sabit, Hussein, Arneth, Borros, Abdel-Ghany, Shaimaa, Madyan, Engy F., Ghaleb, Ashraf H., Selvaraj, Periasamy, Shin, Dong M., Bommireddy, Ramireddy, Elhashash, Ahmed
フォーマット: 論文
言語:英語
出版事項: Philipps-Universität Marburg 2024
主題:
tumor microenvironment
liver cancer
immunotherapy
Medizin
TME
targeted therapy
ECM
Medical sciences Medicine
オンライン･アクセス:PDFフルテキスト
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
その他の書誌記述
要約:Liver cancer represents a substantial global health challenge, contributing significantly to worldwide morbidity and mortality. It has long been understood that tumors are not composed solely of cancerous cells, but also include a variety of normal cells within their structure. These tumor-associated normal cells encompass vascular endothelial cells, fibroblasts, and various inflammatory cells, including neutrophils, monocytes, macrophages, mast cells, eosinophils, and lymphocytes. Additionally, tumor cells engage in complex interactions with stromal cells and elements of the extracellular matrix (ECM). Initially, the components of what is now known as the tumor microenvironment (TME) were thought to be passive bystanders in the processes of tumor proliferation and local invasion. However, recent research has significantly advanced our understanding of the TME’s active role in tumor growth and metastasis. Tumor progression is now known to be driven by an intricate imbalance of positive and negative regulatory signals, primarily influenced by specific growth factors produced by both inflammatory and neoplastic cells. This review article explores the latest developments and future directions in understanding how the TME modulates liver cancer, with the aim of informing the design of novel therapies that target critical components of the TME.
記述事項:Gefördert durch den Open-Access-Publikationsfonds der UB Marburg.
DOI:10.3390/cells13191666

類似資料